文献速递肝胆胰外科围术期管理与 ERAS

肝移植术毕动脉乳酸浓度可早期预测原发性移植物功能障碍

Arterial Lactate Concentration at the End of Liver Transplantation Is an Early Predictor of Primary Graft Dysfunction.
PubMed 文献 · Ann Surg · 2019-01-01

该单中心前瞻性数据库研究纳入2015–2016年296例肝移植受者,评估术毕动脉乳酸浓度(LCEOT)对早期移植物结局的预测价值。LCEOT≥5 mmol/L是预测原发性无功能(PNF)的最佳截断值,并可预测早期移植物功能障碍(EAD)及术后90天死亡,加入BAR评分后预测90天生存的AUC提升至0.87。

要点

  • LCEOT≥5 mmol/L是预测PNF的最佳截断值(Se=83.3%,SP=74.3%)。
  • LCEOT可预测PNF(P=0.02)和EAD(P=0.05)。
  • LCEOT联合BAR评分可改善术后90天生存预测(AUC 0.87 vs 0.74)。

核心结论

  • 术毕动脉乳酸浓度≥5 mmol/L是肝移植早期移植物结局的强预测因子。

主要发现

  • LCEOT≥5 mmol/L预测PNF的敏感度83.3%、特异度74.3%、阳性似然比3.65、阴性似然比0.25、诊断比值比14.44。
  • LCEOT≥5 mmol/L可预测PNF(P=0.02)、EAD(P=0.05)及术后90天内死亡(P=0.06)。
  • LCEOT加入BAR评分后预测术后90天生存的AUC为0.87,优于BAR评分的0.74。
  • LCEOT的预测价值在验证队列中得到确认。

临床怎么用

  • 术毕动脉乳酸浓度≥5 mmol/L可用于识别PNF和EAD高风险受者,辅助术后早期决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although many prognostic factors of primary graft dysfunction after liver transplantation (LT) are available, it remains difficult to predict failure in a given recipient. OBJECTIVE: We aimed to determine whether the intraoperative assay of arterial lactate concentration at the end of LT (LCEOT) might constitute a reliable biological test to predict early outcomes [primary nonfunction (PNF), early graft dysfunction (EAD)]. METHODS: We reviewed data from a prospective database in a single center concerning patients transplanted between January 2015 and December 2016 (n = 296). RESULTS: There was no statistical imbalance between the training (year 2015) and validation groups (year 2016) for epidemiological and perioperative feature. Ten patients (3.4%) presented with PNF, and EAD occurred in 62 patients (20.9%); 9 patients died before postoperative day (POD) 90. LCEOT ≥5 mmol/L was the best cut-off point to predict PNF (Se=83.3%, SP=74.3%, positive likelihood ratio (LR+)=3.65, negative likelihood ratio (LR-)=0.25, diagnostic odds ratio (DOR)=14.44) and was predictive of PNF (P = 0.02), EAD (P = 0.05), and death ≤ POD90 (P = 0.06). Added to the validated BAR-score, LCEOT improved its predictive value regarding POD 90 survival with a better AUC (0.87) than BAR score (0.74). The predictive value of LCEOT was confirmed in the validation cohort. CONCLUSION: As a reflection of both hypoperfusion and tissue damage, the assay of arterial LCEOT ≥5 mmol/L appears to be a strong predictor of early graft outcomes and may be used as an endpoint in studies assessing the impact of perioperative management. Its accessibility and low cost could impose it as a reliable parameter to anticipate postoperative management and help clinicians for decision-making in the first PODs.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Golse N, Guglielmo N, El Metni A, et al. Arterial Lactate Concentration at the End of Liver Transplantation Is an Early Predictor of Primary Graft Dysfunction. Ann Surg. 2019. PMID: 29509585. doi:10.1097/SLA.0000000000002726

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。